Abstract Reactive oxygen species (ROS) play a central role in oxidative stress, which leads to the onset of diseases, such as cancer. Furthermore, ROS contributes to the delicate balance between tumor cell survival and death. However, the mechanisms by which tumor cells decide to elicit survival or death signals during oxidative stress are not completely understood. We have previously reported that ROS enhanced tumorigenic functions in prostate cancer cells, such as transendothelial migration and invasion, which depended on CXCR4 and AKT signaling. Here, we report a novel mechanism by which ROS facilitated cell death through activation of AKT. We initially observed that ROS enhanced the expression of phosphorylated AKT (p-AKT) in 22Rv1 human prostate cancer cells. The tumor suppressor PTEN, a negative regulator of AKT signaling, was rendered catalytically inactive through oxidation by ROS, although the expression levels remained consistent. Despite these events, cells still underwent apoptosis. Further investigation into apoptosis revealed that expression of the tumor suppressor pVHL increased, and contains a target site for p-AKT phosphorylation. pVHL and p-AKT associated in vitro, and knockdown of pVHL rescued HIF1a expression and the cells from apoptosis. Collectively, our study suggests that in the context of oxidative stress, p-AKT facilitated apoptosis by inducing pVHL function.
Introduction
Malignant transformation of cancer cells is driven by the inactivation of tumor suppressors and/or the overwhelming activation of mitogenic molecules, due to aberrant regulation of various signaling pathways that encourage survival functions. One such signaling molecule is protein kinase B (AKT). In cancer cells, AKT is an established molecule that regulates cellular functions that encourages malignancy, such as cell survival, proliferation, and migration [1] . Upstream of AKT, phosphoinositide 3-kinase (PI3K) enzymatically converts phosphatidylinositol 3,4-triphosphase (PIP2) to phosphatidylinositol 3,4,5-triphosphase (PIP3), which recruits and activates PDK, thereby activating AKT by phosphorylation. Under normal physiologic conditions, AKT is activated by signaling receptors such as receptor tyrosine kinases (RTK) and G-protein coupled receptors (GPCR). AKT can also be constitutively active, independent of receptor signaling, due to mutations and/or constitutively active upstream signaling molecules [2] . AKT signaling provides protection from apoptosis and encourages uncontrolled cell-cycle progression. These functions are innate to AKT in normal energy metabolism, which makes it favorable to tumor cell survival [3] . However, an emerging concept is that AKT may also sensitize cells to senescence and apoptosis [4] .
Reactive oxygen species (ROS) are oxygen-derived free radicals, such as hydroxyl radicals, peroxides, and superoxides, that are endogenously produced in the mitochondria by complexes I and III; ROS is also produced in the cytosol by NAD(P)H oxidase systems and enzymes, such as xanthine oxidases, cytochrome p450, and cyclooxygenases [5] . Cellular damage is a major consequence induced by ROS accumulation, which is a natural byproduct of energy metabolism. Cellular insults by ROS include DNA lesions, protein oxidation, and lipid peroxidation [6] . Conversely, ROS induces tumorigenic functions such as proliferation and metastasis [7] . The delicate balance of ROS concentration that determines the lifespan of the cell remains unknown [7] . Concerning oxidative stress, hypoxic inducible factor 1a (HIF1a) has long been involved in preventing cells from apoptosis in response to ROS accumulation [7] .
The HIF1a complex of proteins enhances expression of targeted genes that adjust cells to oxidative stress and/or cell survival. The complex consists of a regulatory HIF1a subunit and the constitutively expressed HIF1b subunit, both members of the basic helix-loop-helix (bHLH) and PER-ARNT-SIM (PAS) families of transcription factors [8] . A hydroxylated HIF1a binds to the tumor suppressor von Hippel-Lindau protein (pVHL), which contains E3 ligase activity. The binding of HIF1a and pVHL facilitates ubiquitination of HIF1a and subsequent proteasomal degradation of the complex [9] . For this reason, pVHL has been recognized as a tumor suppressor [10] . These collective events implicate ROS in apoptosis. Reports have shown that ROS plays a critical role in determining the cell-cycle and senescence in cells. For example, mouse embryonic fibroblast developed long telomeres when grown at ambient oxygen levels [6] . Likewise, human diploid cells underwent senescence at low oxygen conditions [11] .
Currently, chemotherapeutic agents are used to induce ROS-mediated apoptosis in tumor cells, thereby decreasing malignancy. A number of anti-cancer drugs exert their effect by causing DNA damage which leads to apoptosis induction [12] . Hydrogen peroxide and super oxide anion (O 2 -) participate in apoptosis and DNA damage induced by some anti-cancer drugs, however, the precise mechanism of apoptosis via ROS formation remains to be clarified. For instance, Jacaranone and other small molecule compounds have induced apoptosis through oxidative stress [13, 14] , along with concomitant downregulation of AKT signaling and expression. Downregulation of AKT is the canonical concept of ROS-mediated apoptosis. However, Nogueira et al. [4] described that increased expression of phosphorylated AKT (p-AKT) determined replicative senescence of mammalian cells in culture and mediated apoptosis induced by oxidative stress. What differed in this report from long-standing reports on AKT and apoptosis was that activation, not inhibition or downregulation, sensitized cell to apoptosis. Moreover, rapamycin, which is usually cytostatic, sensitized cells to ROS-mediated cell death through activation of AKT [4] . Furthermore, increased p-AKT deficiency exerted resistance to senescence induced by oxidative stress [4] .
In this study, we observed that prostate cancer cells responded to ROS by inducing apoptosis, despite increased expression of p-AKT. Several signatures of apoptosis were observed, including decreased HIF1a expression. Further studies revealed that ROS-mediated decrease of HIF1a correlated with increased pVHL expression. We then investigated a correlation between ROS-mediated activation of AKT and pVHL expression. We found that activated, not downregulated, AKT enhanced pVHL expression, thereby targeting cells for apoptosis. Finally, downregulation of pVHL rescued cells from apoptosis. Collectively, these findings may change the paradigm of AKT expression in tumor apoptosis, as it is one of the most targeted molecules in chemotherapeutics.
Materials and methods
Cell culture, antibodies, and reagents Human prostate cancer cell line 22Rv1 was obtained from American Type Culture Collection (ATCC) and maintained in complete RPMI 1640 media (10 % Fetal Bovine Serum (FBS), 1 % non-essential amino acids and 1 % antibioticantimycotic), or starvation media (RPMI only), at 37°C and 5 % CO 2 . Cells were maintained at 60-80 % confluency. Hydrogen peroxide (H 2 O 2 ) was used as our model of ROS (Acros Organics). N-acetyl-cysteine (NAC) was from Sigma Aldrich; cobalt chloride (CoCl 2 ) and N-ethylmaleimide (NEM) were from EMD Chemicals; LY294002 was from Cayman Chemicals. Cell culture supplies were from MediaTech and the following human antibodies were from Cell Signaling: anti-pVHL, anti-PTEN, anti-AKT, anti-phospho-AKT (p-AKT), and anti-cleaved-PARP; anti-HIF1a was from BD Bioscience; anti-a-Tubulin was from Santa Cruz Biotech.
Proliferation (viability) assay
Cell proliferation was assessed by a MTT dye conversion assay at 570 nm following manufacturer's instructions (Trevigen). In triplicates, 1 9 10 3 cells/well were seeded in a 96-well flat-bottomed plate. Cells were serum-starved for 4 h before treatments in RPMI at 37°C in 5 % CO 2 . At each time point (24 and 48 h), the treatments were replaced with 100 lL of RPMI media and then incubated with 10 lL of MTT reagent for 2 h at 37°C, followed by 100 lL of detergent reagent at 37°C for 2 h. Proliferation (viability) was measured at 570 nm using a microplate reader (Bio-Tek Synergy HT). Results were quantified using GraphPad Prism 5 statistical software.
Apoptosis assay
Annexin-V Apoptosis Detection Kit Plus (MBL) was used to quantify the levels of apoptosis in samples, according to the manufacturer's specifications. In brief, cells were trypsinized, centrifuged, and resuspended in 500 lL of 19 binding buffer before adding Annexin V-FITC. After 15 min of incubation, apoptosis was analyzed by flow cytometry (Accuri C6) or microplate reader at 488 nm ex/ 578 nm em (Bio-Tek Synergy HT) for the detection of Annexin V-FITC.
Western blot analysis 3 9 10 5 cells were harvested in lysis buffer (Cell Signaling) as previously described [15] . Equal concentrations of total cell lysate were resolved by 10 % SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane. Non-specific binding sites were blocked with 5 % non-fat dry milk/0.1 % Tween 20/1XTBS, followed by an incubation with primary antibodies for the proteins of interest in 3 % Bovine Serum Albumin-Tris-buffered saline/Tween 20 (BSA-TBS/T; p-AKT, AKT, PTEN, HIF1a, cleaved-PARP). Protein complexes were detected with horseradish peroxidase-conjugated secondary antibodies (JacksonImmuno Research) and enhanced chemiluminescence reagents (Pierce). Exposed films were developed using an automated X-ray processor (Kodak X-OMAT M35A Processor).
Western blot analysis of alkylated PTEN
The oxidation state of PTEN was investigated using alkylating agents, as described by our laboratory and Lee et al. [7, 16] . In brief, 1 9 10 6 cells/well were treated with 0.25 mM H 2 O 2 and scraped into alkylating lysis buffer (20 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1 mmol/L Na 2 EDTA, 1 mmol/L EGTA, 1 % Triton, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L b-glycerophosphate, 1 mmol/L Na 3 VO 4 , 1 mg/mL leupeptin, 1 mmol/L PMSF, 2 % SDS, and 40 mM N-ethylmaleimide (NEM)). Cell lysates were sonicated, and equal amounts of protein (60 lg) were incubated at room temperature for 30 min. Total protein lysates were diluted in sample buffer without b-mercaptoethanol, resolved by 10 % SDS-PAGE and transferred to a PVDF membrane. Reduced and nonreduced forms of PTEN were detected as described above.
PCR amplification
Total RNA was isolated with Total RNA Kit-I (Omega Bio-TeK), as described by the manufacturer. Total RNA was reversed transcribed with M-MLV Transcriptase (Promega) to generate cDNA for PCR amplification. Specific sense and anti-sense primers for PTEN, HIF1a and housekeeping gene L19, were synthesized by Integrated DNA Technologies as follows: PTEN (forward GGA CGA ACT GGT GTA ATG ATA TG; reverse TCT ACT GTT TTT GTG AAG TAC AGC), HIF1a (forward ACA TAA AGT CTG CAA CAT GGA AGG; reverse TTG ATG GGT GAG GAA TGG GTT C) and L19 (forward GAA ATC GCC AAT GCC TC; reverse TCT TA ACC TC GAG CCT CA).
Short interfering RNA transfection
Transient transfection of pVHL-specific short interfering RNA (siRNA; Santa Cruz) was carried out in 22Rv1 cells using JetPrime transfection reagent (Polyplus Transfection). In brief, cells (5 9 10 5 ) were plated in 100-mm dishes and transfected with various concentrations of respective siRNA in 20 % FBS/RPMI at 37°C and 5 % CO 2 for 18 h. Transfected cells were serum-starved, treated and then harvested for western blot analysis.
Phosphatase activity assay
Treated cells (1 9 10 6 cells/well) were harvested in 19 lysis buffer (Cell Signaling). 500 lg of total protein were incubated with a PTEN-specific primary antibody overnight at 4°C, then immunoprecipitated with protein A/G agarose beads (Santa Cruz) for 4 h at 4°C. Samples were centrifuged for 10 min at 10,000 rpm, the supernatant was collected and the bead pellet was then resuspended in 40 lL of 19 lysis buffer. Western blot analysis was performed on total protein lysate, supernatant, and bead pellets for PTEN. The PIP phosphatase assay, as described by Maehama and Dixon [17] was adapted to a 96-well format. PIP3 lipid (Echelon, Salt Lake City, UT) was combined with 10 lL of immunoprecipitated PTEN and allowed to dephosphorylate PIP3 to PIP2 at 37°C for 2 h. 100 lL of malachite green was added to react with free phosphates, representing the successful dephosphorylation of PIP3, and the absorbance for the phosphatase products was measured at 620 nm with a microplate reader at increasing time intervals. Each data point was assayed in triplicate, and all experiments were repeated at least three times.
Statistics and quantifications
Data are presented as the mean ± SE of at least three independent experiments and were analyzed by 2-way ANOVA or Student's t test. All statistical analyses were done, and all graphs generated, using GraphPad Prism 5.0 software (GraphPad).
Results

H 2 O 2 accumulation induced phospho-AKT expression
In the following study, we used H 2 O 2 as our model of ROS and human prostate cancer cells, 22Rv1, was a tumor model. We have previously observed that H 2 O 2 induced expression of p-AKT in DU145 prostate cancer cells, suggesting activation of survival mechanisms and functions [7] . Likewise, we observed a gradual increase in p-AKT expression in a concentration-dependent manner in 22Rv1 cells (Fig. 1a) . We chose 0.25 mM of H 2 O 2 as a median concentration and decided to treat cells at various time points. We found that exposing cells to 0.25 mM H 2 O 2 at increasing time points correlated with increasing p-AKT expression (Fig. 1b) . For subsequent experiments, we chose 0.25 mM H 2 O 2 for 4 h as our treatment.
The tumor suppressor PTEN negatively regulates the PI3K/ AKT pathway by converting PIP3 to PIP2, thus removing the signal that would activate AKT [18] . We investigated whether ROS-mediated p-AKT expression was due to decreased expression of PTEN. H 2 O 2 did not alter the expression of PTEN at the mRNA or at the protein level; expression levels remained consistent (Fig. 2a) . Previous reports have shown that ROS accumulation oxidized PTEN catalytic domain by forming a disulfide bond between amino acids cysteine(s) 71 and 124 within the active site, thus inactivating its phosphatase function [16] . We determined whether H 2 O 2 oxidizes PTEN, thereby inactivating its catalytic function, since there was no change in PTEN expression levels. By alkylation method [7] , we found increased expression of the oxidized form of PTEN (a low molecular weight band) in cells treated with H 2 O 2 compared to untreated cells (Fig. 2b) (Fig. 2c) . Although the expression levels did not change, H 2 O 2 inactivated PTEN catalytically; this may have contributed to increased expression of p-AKT.
H 2 O 2 induced apoptosis in 22Rv1 cells
The activation of oncogenic pathways, such as AKT, and inactivation of tumor suppressor molecules, such as PTEN, are strong indicators for cell proliferation, growth, and tumor cell progression [19] . Hence, we determined whether the observed H 2 O 2 -mediated increase in p-AKT expression and inactivation of PTEN led to increase cell viability, by performing a MTT assay. Surprisingly, we found that H 2 O 2 -treated cells decreased in cell viability compared to untreated control cells (Fig. 3a) . Furthermore, cells treated with NAC, a ROS scavenger and 0.25 mM H 2 O 2 showed similar viability levels compared to untreated control (Fig. 3a) . The decrease in viability was unexpected; therefore, we investigated whether cells may have entered cell death. Bright field microscopy revealed that cells were phenotypically smaller, condensed and granular in the presence of H 2 O 2 , compared to untreated control cells (Fig. 3b) , which was indicative of apoptosis [20] . Cell death in 22Rv1 cells was confirmed by an annexin-V assay, where 47 % of H 2 O 2 -treated 22Rv1 cells were positive for apoptosis, compared to 19.9 % of untreated cells (Fig. 3c) . We further substantiated apoptosis in 22Rv1 cells by analyzing for cleaved-PARP, an apoptotic marker that indicates caspase-3 activation, and HIF1a, a cell survival marker [21] . Hydrogen peroxide-treated cells expressed cleaved-PARP, which was abrogated by NAC (Fig. 3d) . Furthermore, treating cells with 0.25 mM H 2 O 2 reduced HIF1a expression at the protein level compared to untreated control; there was no change in HIF1a mRNA levels, indicating that H 2 O 2 regulated HIF1a at the translational level and not at transcription (Fig. 3e) .
H 2 O 2 inhibited HIF1a expression through pVHL
HIF1a protein is regulated by the tumor suppressor pVHL, which contains E3 ligase activity that tags HIF1a for proteasomal degradation [22] . Therefore, we determined whether H 2 O 2 -mediated reduction of HIF1a expression correlated with pVHL activity. The expression levels of (Fig. 4a) . We decreased pVHL expression by siRNA to determine whether HIF1a would be affected. We investigated three concentrations of pVHL siRNA: 15, 30, and 50 nM. We saw diminished knockdown at 15 and 30 nM, and complete knockdown at 50 nM (data not shown); however the cells would easily contaminate at 30 nM or become unhealthy at 50 nM. Subsequently, we decided to use 15 nM. Upon treating pVHL-knockdown cells with 0.25 mM H 2 O 2 , we observed an increase on HIF1a expression compared to untreated cells (Fig. 4b, c) , indicating that expression of HIF1a and pVHL are inversely correlated. These results suggest that ROS mediates apoptosis and degrades HIF1a through pVHL. pVHL activity depended on p-AKT Previous studies have shown that pVHL activity was involved in directing apoptosis [23] . Roe et al. [24] demonstrated that phosphorylation of pVHL at serine 111 (S 111 ) led to an increase in function. Interestingly, S 111 is a residue within a consensus target motif for p-AKT (Fig. 5a ) and sought to determine whether p-AKT is involved in pVHL activity. Cells were treated with combinations of H 2 O 2 and LY294002, after which pVHL was immunoprecipitated. A western blot analysis was performed using an monoclonal antibody-specific for the phosphorylated substrate consensus sequence, RXXS. We found increased expression of pVHL at the phosphorylated AKT consensus motif in cells treated with 0.25 mM H 2 O 2 compared to untreated control cells (Fig. 5b) . This increase diminished when AKT was inhibited with LY294002 alone, and in combination with 0.25 mM H 2 O 2 (Fig. 5b) .
Increased pVHL activity enhances apoptosis [23] . Therefore, we determined whether diminished pVHL would rescue cells from apoptosis. Cells were incubated with siRNA specific for pVHL, before treating with H 2 O 2 and assaying for signatures of apoptosis. Downregulating pVHL prevented apoptosis, as observed by reduced annexin-V (Fig. 5c ) and cleaved-PARP (Fig. 5d) ; H 2 O 2 did not direct the cells toward apoptosis.
Discussion
In this study, we propose a regulatory mechanism by which cells die in response to ROS accumulation that uses AKT. In literature, ROS generation initiates signaling cascades, such as the AKT pathway, that can enhance or inhibit survival mechanisms [4, 25] . We initially observed that ROS induced p-AKT expression in 22Rv1 prostate cancer cells, which was consistent with previously published reports [7, 25] . Herein, and in previous data, we have shown that ROS-mediated upregulation of p-AKT a Serum-starved cells were treated with H 2 O 2 for 4 h. Total protein (40 lg) was analyzed for PTEN expression by western blot analysis using a specific antibody; a-Tubulin served as a loading control. Total RNA (2 lg) was isolated and reverse transcribed to cDNA for PCR amplification using primers specific for PTEN; L19 served as a loading control. b Serum-starved cells were treated with H 2 O 2 for 4 h, followed by alkylation as previously described [7] . Total protein lysate (60 lg) was analyzed for oxidized and reduced forms of PTEN by western blot analysis using a specific antibody; a-Tubulin served as a loading control. c Equal concentrations of total protein lysate were allowed to dephosphorylate PIP3 to PIP2, before the quantitation for free phosphates via a phosphatase assay expression was not due to diminished levels of PTEN expression [7] . Lee et al. [16] described that H 2 O 2 induced disulfide bonding within the active sites of PTEN, rendering it inactive. We observed catalytic inactivation of PTEN, where it failed to convert PIP3 to PIP2 in the presence of H 2 O 2 , thus allowing increased expression of p-AKT. Likewise, Ha et al. [26] demonstrated that ROS accumulation inactivated PTEN catalytic function and promoted AKT expression in hepatocellular carcinoma. Considering the effects of ROS on PTEN function, it is plausible to suggest that ROS may indirectly regulate p-AKT through catalytic inactivation of PTEN.
The development and progression of cancer cells are generally due to the inactivation of tumor suppressor genes, such as PTEN, and the activation of oncogenes, such as AKT. We observed this effect upon treatment with ROS, thereby suggesting that cells would progress toward cell survival [7] . On the contrary, cells treated with H 2 O 2 demonstrated a decrease in cell viability compared to control, and demonstrated several signatures of apoptosis, such as an increase in extracellular annexin-V, increase in cleaved-PARP and decreased HIF1a. Indeed, ROS accumulation leads to apoptosis, but it was interesting to observe a gradual increase in expression of survival molecule p-AKT, suggesting that expressed p-AKT may have more of a role in apoptosis than attributed.
The stabilization of HIF1a is dependent on the activity of the E3 protein ligase, pVHL, which targets HIF1a toward proteasomal degradation. Thus, a decrease in HIF1a inversely correlates with an increase in pVHL activity. We observed that silencing pVHL restored HIF1a expression in the presence of ROS. These results support Park et al. where cellular toxicity by zinc ions inhibited HIF1a prolyl hydroxylase (PHD) activity, and blocked annexin-V by flow cytometry, and d cleaved-PARP by western blot analysis using a specific antibody; a-Tubulin served as a loading control. e Serum-starved cells were treated with H 2 O 2 for 4 h. Total protein lysate (100 lg) was analyzed for HIF1a expression by western blot analysis using a specific antibody; a-Tubulin served as a loading control. Total RNA (2 lg) was isolated and reverse transcribed to cDNA for PCR amplification using primers specific for HIF1a; L19 served as a loading control. *P\0.05 pVHL binding to HIF1a to induce its degradation in prostate cancer cells [27] . An increase in pVHL expression depends on phosphorylation by various molecules, such as glycogen synthase kinase 3 (GSK3) and checkpoint kinase 2 (chk2) [24, 28] . Notably, Roe et al. [24] demonstrated that phosphorylation of pVHL at serine 111 (S 111 ) by chk2 led to increased activity, and subsequently, apoptosis. The S 111 residue in pVHL is within a motif ( 108 RIHS 111 ) that is homologous to a consensus p-AKT substrate motif (RXXS) [29] . Several targets of p-AKT, such as BAD, MDM2, and FOXO1, contain the RXXS motif and are phosphorylated by p-AKT [30] [31] [32] (Table 1) . This led us to believe that phosphorylation of this putative AKT-substrate site on pVHL may facilitate pVHL-mediated activity, and with the indicated primary antibodies, and western blot analysis was performed to detect pVHL or p-AKT-RXXS. c Graph represents quantitation of annexin-V fluorescence expression. d Cleaved-PARP expression was analyzed by western blot analysis using a specific antibody; a-Tubulin served as a loading control. *P\0.05 subsequently, apoptosis. Accordingly, we observed that knockdown of pVHL prevented ROS-mediated cell death.
The idea of AKT positively influencing a tumor suppressor is a conflicting concept, but has been described. For instance, Hinton et al. [33] demonstrated that the tumor suppressor BRCA1 contained a phosphorylation site for AKT, which enhanced BRCA1 localization to the nucleus and BRCA1-dependent transcriptional activity. Nogueira et al. [4] has shown that p-AKT mediated tumor suppressive functions by inhibiting FOXO, which led to apoptosis in a ROS-dependent manner. Another mechanism by which AKT may exert its tumor suppressive functions is by inducing the activity of apoptin, a pro-apoptotic molecule [34] .
AKT functioning as an anti-survival molecule is novel and emerging. Most studies view AKT as a cell survival molecule that functions to prevent apoptosis. However, the emerging notion of AKT working as a pro-apoptotic molecule suggests that AKT should not be exclusively labeled as a survival molecule, and may contribute to chemotherapeutics (Fig. 6) . Taken together, our study supports the emerging role of p-AKT in promoting apoptosis and tumor suppressive functions [35] . However, additional studies are warranted to fully elucidate the divergent role of ROS on AKT-mediated cell survival and death in tumors. Fig. 6 Proposed schematic for p-AKT and pVHL in mediating apoptosis. Putatively, the accumulation of ROS promoted AKT activation with concomitant inhibition of PTEN catalytic activity. Increased p-AKT phosphorylated pVHL, which targeted HIF1a for proteasomal degradation. Collectively, these activities led to apoptosis
